EG665802 Inhibitors

The chemical class referred to as Pramel35 Inhibitors includes compounds that interact with the ubiquitin-proteasome system (UPS) and related cellular mechanisms, thereby indirectly affecting the activity of the Pramel35 protein. These inhibitors target various enzymes and processes that are upstream or parallel to the function of Pramel35, which is involved in ubiquitin ligase-substrate adaptor activity within the Cul2-RING ubiquitin ligase complex. For example, proteasome inhibitors such as MG132, Bortezomib, Lactacystin, and Clasto-Lactacystin β-lactone obstruct the proteasomal degradation pathway, leading to the accumulation of ubiquitinated proteins within the cytoplasm. This accumulation can result in a feedback inhibition of the ubiquitination process that Pramel35 is part of, as the system becomes congested with undegraded substrates.

Further, compounds like MLN4924 and Pevonedistat inhibit the NEDD8-activating enzyme, which is essential for the neddylation of Cullin proteins that form the scaffold of the Cullin-RING E3 ligases, to which Pramel35 can bind. Interference with this process can disrupt the assembly and function of the E3 ligase complex, affecting Pramel35's role. Other chemicals in this class, such as PYR-41, target the ubiquitin-activating enzyme E1, preventing the initial step of ubiquitin conjugation to substrates, while IU1, HBX 41108, and WP1130 are inhibitors of deubiquitinating enzymes (DUBs) like USP14 and USP7, which can lead to an altered ubiquitin landscape that influences the ubiquitination cycle.